Instituto de Fisiologia Experimental (IFISE), CONICET, Facultad de Ciencias Bioquimicas y Farmaceuticas, Universidad Nacional de Rosario, S2002LRL, Rosario, Argentina.
Front Biosci (Landmark Ed). 2012 Jan 1;17(4):1201-18. doi: 10.2741/3981.
Vectorial transport of osmotically active solutes from blood into bile is essential for bile flow generation. Therefore, the localization status of hepatocellular transporters involved in this function is critical. These transporters are localized either in the plasma membrane or in an endosomal, submembranous compartment, from where they undergo recycling to the plasma membrane. The balance between exocytic targeting/endocytic internalization from/to this recycling compartment is therefore a chief determinant of the liver capability to secrete bile. Furthermore, its impairment may lead to sustained endocytic internalization, eventually resulting in transporter degradation. Exacerbated internalization of hepatocellular transporters occurs in several experimental models of cholestasis, and also in most human cholestatic liver diseases. This review outlines the possible mechanisms explaining this alteration (e.g., alteration of the organization of actin or actin-transporter linking proteins), and the mediators involved (e.g., activation of "cholestatic" signaling pathways). Finally, several experimental therapeutic approaches based upon the administration of compounds that stimulate exocytic targeting of canalicular transporters (e.g., cAMP, tauroursodeoxycholate) are described with regard to their capability to prevent cholestatic alterations resulting from transporter internalization.
渗透活性溶质从血液向胆汁的向量转运对于胆汁流动的产生至关重要。因此,参与此功能的肝细胞转运体的定位状态至关重要。这些转运体位于质膜或亚膜的内体区室中,从那里它们经历再循环回到质膜。因此,外排靶向/内吞内化从/到这个再循环隔室的平衡是肝脏分泌胆汁能力的主要决定因素。此外,其功能障碍可能导致持续的内吞内化,最终导致转运体降解。在几种胆汁淤积的实验模型中以及在大多数人类胆汁淤积性肝病中,肝细胞转运体的内化作用加剧。这篇综述概述了可能的解释这种改变的机制(例如,肌动蛋白或肌动蛋白-转运蛋白连接蛋白的组织改变),以及涉及的介质(例如,“胆汁淤积”信号通路的激活)。最后,描述了几种基于给予刺激胆小管转运体外排靶向的化合物的实验治疗方法(例如,cAMP、牛磺熊脱氧胆酸),以预防由于转运体内化导致的胆汁淤积改变的能力。